MUSTANG BIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
MUSTANG BIO, INC. (MBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $5.73 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2019-03-18
- MUSTANG BIO, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2017-12-31 was -$5.73M.
- MUSTANG BIO, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2017-09-30 was $230.00K.
- MUSTANG BIO, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2018 was $5.73, a 0.00% change from fiscal 2017.
- MUSTANG BIO, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2017 was $5.73.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2018-12-31 | $5.73 10-K · filed 2019-03-18 | |||
| 2017-12-31 | -$5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | -$5.50M derived: sum of 2 quarters · filed 2018-03-29 | $5.73 10-K · filed 2018-03-29 | |
| 2017-09-30 | $230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $5.73M 10-Q · filed 2017-11-14 | ||
| 2017-06-30 | $5.50M 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |